Evaluation of Intravitreal Kenalog Toxicity in Humans

Ophthalmology

Volumn 114, Issue 4, 2007, Pages 724-731

  Lang, Yaron ^a   Leibu, Rina ^b   Shoham, Nir ^a   Miller, Benjamin ^b   Perlman, Ido ^c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; B WAVE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DARK ADAPTATION; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LIGHT ADAPTATION; LOW LEVEL LASER THERAPY; MALE; OBSERVATIONAL STUDY; OPTICAL RESOLUTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA; RETINA MACULA EDEMA; VISUAL ACUITY;

ADULT; AGED; DARK ADAPTATION; DIABETIC RETINOPATHY; DRUG EVALUATION; ELECTRORETINOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33947602026     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.08.044     Document Type: Article

References (45)

1. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
2. Sutter F.K., Simpson J.M., and Gillies M.C. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 (2004) 2044-2049
3. Jonas J.B., Akkoyun I., Kreissig I., and Degenring R.F. Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide: a comparative, non-randomized study. Br J Ophthalmol 89 (2005) 321-326
4. Chieh J.J., Roth D.B., Liu M., et al. Intravitreal triamcinolone acetonide for diabetic macular edema. Retina 25 (2005) 828-834
5. Greenberg P.B., Martidis A., Rogers A.H., et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86 (2002) 247-248 [letter]
6. Jonas J.B., Akkoyun I., Kamppeter B., et al. Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion. Eur J Ophthalmol 15 (2005) 751-758
7. Ip M.S., Gottlieb J.L., Kahana A., et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 122 (2004) 1131-1136
8. Cekic O., Chang S., Tseng J.J., et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina 25 (2005) 846-850
9. Chen S.D., Lochhead J., Patel J.K., and Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 88 (2004) 154-155
10. Cekic O., Chang S., Tseng J.J., et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25 (2005) 851-855
11. Antcliff R.J., Spalton D.J., Stanford M.R., et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
12. Kok H., Lau C., Maycock N., et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112 (2005) 1916-1921
13. Challa J.K., Gillies M.C., Penfold P.L., et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 26 (1998) 277-281
14. Jonas J.B., Degenring R.F., Kreissig I., et al. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide: a prospective comparative nonrandomized study. Eye 19 (2005) 163-170
15. Spaide R.F., Sorenson J., and Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 (2005) 301-304
16. Rechtman E., Danis R.P., Pratt L.M., and Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 88 (2004) 344-347
17. Peyman G.A., Cheema R., Conway M.D., and Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20 (2000) 554-555
18. Furino C., Micelli Ferrari T., Boscia F., et al. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina 23 (2003) 771-776
19. Sonoda K.H., Sakamoto T., Enaida H., et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111 (2004) 226-230
20. Shah G.K., Rosenblatt B.J., Blinder K.J., et al. Triamcinolone-assisted internal limiting membrane peeling. Retina 25 (2005) 972-975
21. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
22. Gillies M.C., Simpson J.M., Billson F.A., et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122 (2004) 336-340
23. Jonas J.B., Degenring R., Kreissig I., and Akkoyun. Safety of intravitreal high-dose reinjections of triamcinolone acetonide. Am J Ophthalmol 138 (2004) 1054-1055
24. Ozkiris A., and Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 40 (2005) 63-68
25. Jonas J.B., Degenring R.F., Kreissig I., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112 (2005) 593-598
26. Gillies M.C., Kuzniarz M., Craig J., et al. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 112 (2005) 139-143
27. Jonas J.B., Kreissig I., and Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87 (2003) 24-27
28. Jonas J.B., Degenring R., Vossmerbauemer U., and Kamppeter B. Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide. Eur J Ophthalmol 15 (2005) 462-464
29. Cekic O., Chang S., Tseng J.J., et al. Cataract progression after intravitreal triamcinolone injection. Am J Ophthalmol 139 (2005) 993-998
30. Moshfeghi D.M., Kaiser P.K., Scott I.U., et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136 (2003) 791-796
31. Moshfeghi A.A., Scott I.U., Flynn Jr. H.W., and Puliafito C.A. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 138 (2004) 489-492
32. Ciardella A.P., Klancnik J., Schiff W., et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88 (2004) 1131-1136
33. Loewenstein A., Zemel E., Lazar M., and Perlman I. The effects of Depo-Medrol preservative on the rabbit visual system. Invest Ophthalmol Vis Sci 32 (1991) 3053-3060
34. McCuen II B.W., Bessler M., Tano Y., et al. The lack of toxicity of intravitreal administered triamcinolone acetonide. Am J Ophthalmol 91 (1981) 785-788
35. Dierks D., Lei B., Zhang K., and Hainsworth D.P. Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 123 (2005) 1563-1569
36. Kivilcim M., Peyman G.A., El-Dessouky E.S., et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 31 (2000) 474-478
37. Hida T., Chandler D., Arena J.E., and Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101 (1986) 190-195
38. Morrison V.L., Koh H.J., Cheng L., et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 26 (2006) 339-344
39. Marmor MF, Zrenner E, International Society for Clinical Electrophysiology of Vision. Standard for clinical electrophysiology (1999 update). Doc Ophthalmol 1998-1999;97:143-56.
40. Yonemura D., and Kawasaki K. New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 48 (1979) 163-222
41. Danis R.P., Bingaman D.P., Yang Y., and Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103 (1996) 2099-2104
42. Ciulla T.A., Criswell M.H., Danis R.P., and Hill T.E. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 119 (2001) 399-404
43. Schindler R.H., Chandler D., Thresher R., and Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 93 (1982) 415-417
44. Holopigian K., Seiple W., Lorenzo M., and Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci 33 (1992) 2773-2780
45. Simonsen S.E. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh) 58 (1980) 865-878